Copaxone and Centrum silver drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Copaxone (glatiramer acetate) and Centrum silver (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e). Common drug interactions include herpes zoster among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Copaxone and Centrum silver. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.

What is Copaxone?

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. eHealthMe is studying from 56,931 Copaxone users. Check the latest studies of Copaxone.

What is Centrum silver?

Centrum silver has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 19,997 Centrum silver users. Check the latest studies of Centrum silver.

On Jul, 10, 2026

51 people who take Copaxone and Centrum silver together, and have interactions are studied.

Copaxone and Centrum silver drug interactions.

What are the common drug interactions of Copaxone and Centrum Silver, by gender? *:

female:

Herpes zoster
Hot flush (sudden feelings of heat)
Injection site erythema (redness at injection site)
Injection site haemorrhage (bleeding from injection site)
Loss of consciousness
Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
Myalgia (muscle pain)
Nasopharyngitis (inflammation of the nasopharynx)
Neoplasm malignant (cancer tumour)
Rib fracture

male:

Dizziness
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Heart rate decreased
Hyperhidrosis (abnormally increased sweating)
Hypoaesthesia (reduced sense of touch or sensation)
Hypokinesia (decreased bodily movement)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Ill-defined disorder
Injection site erythema (redness at injection site)
Injection site haemorrhage (bleeding from injection site)

What are the common drug interactions of Copaxone and Centrum Silver, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Dry mouth
Limb discomfort (discomfort in leg)
Mobility decreased (ability to move is reduced)
Pain in extremity
Therapeutic response unexpected
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Fall
Headache (pain in head)
Hypoaesthesia (reduced sense of touch or sensation)
Injection site erythema (redness at injection site)

60+:

Dizziness
Hypoaesthesia (reduced sense of touch or sensation)
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Dry eye (lack of adequate tears)
Dysphagia (a condition in which swallowing is difficult or painful)
Eye pruritus (eye itching)
Headache (pain in head)
Insomnia (sleeplessness)
Muscle spasms (muscle contraction)
Optic neuritis (optic nerve inflammation)

What are the existing conditions these people have? *

Gait Disturbance: 11 people, 21.57%
Muscle Spasms (muscle contraction): 8 people, 15.69%
Nasal Polyps (masses that develop in the lining of the nose): 3 people, 5.88%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Copaxone and Centrum silver?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously